降(Jiang)低(Di)疾(Ji)病(Bing)进(Jin)展(Zhan)风(Feng)险(Xian)40% FDA批(Pi)准(Zhun)赛(Sai)诺(Nuo)菲(Fei)CD38抗(Kang)体(Ti)上(Shang)市(Shi)
网(Wang)站(Zhan)编(Bian)辑(Ji):(?)嘉(Jia)兴(Xing)市(Shi)舒(Shu)福(Fu)特(Te)生(Sheng)物(Wu)科(Ke)技(Ji)有(You)限(Xian)公(Gong)司(Si) │(?) 发(Fa)布(Bu)时(Shi)间(Jian):(?)2020-03-31 (?)
3日(Ri),(?)美(Mei)国(Guo)FDA宣(Xuan)布(Bu)批(Pi)准(Zhun)赛(Sai)诺(Nuo)菲(Fei)((?)Sanofi)(?)公(Gong)司(Si)开(Kai)发(Fa)的(De)CD38抗(Kang)体(Ti)Sarclisa((?)isatuximab-irfc)(?)上(Shang)市(Shi),(?)与(Yu)泊(Bo)马(Ma)度(Du)胺(An)((?)pomalidomide)(?)和(He)地(Di)塞(Sai)米(Mi)松(Song)((?)dexamethasone)(?)联(Lian)用(Yong),(?)治(Zhi)疗(Liao)成(Cheng)年(Nian)多(Duo)发(Fa)性(Xing)骨(Gu)髓(Sui)瘤(Liu)((?)MM)(?)患(Huan)者(Zhe)...